B F Haynes, Y Yasutomi, J V Torres, M B Gardner, A J Langlios, D P Bolognesi, T J Matthews, R M Scearce, D M Jones, M A Moody
{"title":"在灵长类动物中使用合成肽诱导高滴度中和抗体和MHC i类限制性细胞毒性T细胞对抗获得性免疫缺陷综合征逆转录病毒:一种基于hla的疫苗策略","authors":"B F Haynes, Y Yasutomi, J V Torres, M B Gardner, A J Langlios, D P Bolognesi, T J Matthews, R M Scearce, D M Jones, M A Moody","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23470,"journal":{"name":"Transactions of the Association of American Physicians","volume":"106 ","pages":"33-41"},"PeriodicalIF":0.0000,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.\",\"authors\":\"B F Haynes, Y Yasutomi, J V Torres, M B Gardner, A J Langlios, D P Bolognesi, T J Matthews, R M Scearce, D M Jones, M A Moody\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":23470,\"journal\":{\"name\":\"Transactions of the Association of American Physicians\",\"volume\":\"106 \",\"pages\":\"33-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1993-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transactions of the Association of American Physicians\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transactions of the Association of American Physicians","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.